Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix

International Journal of Gynecological Cancer

Volumn 18, Issue 6, 2008, Pages 1300-1304

  Kodama, J ^a   Takemoto, M ^a   Seki, N ^a   Nakamura, K ^a   Hongo, A ^a   Moriya, S ^a   Kanazawa, S ^a   Hiramatsu, Y ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Chemoradiation; Ifosfamide; Nedaplatin; Phase I study

Indexed keywords

IFOSFAMIDE; NEDAPLATIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSE ESCALATION; FEMALE; HEMOGLOBINOPATHY; HUMAN; INFECTION; LEUKOPENIA; LIVER TOXICITY; MULTIPLE CYCLE TREATMENT; NAUSEA; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; RECOMMENDED DRUG DOSE; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; THROMBOCYTE DISORDER; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IFOSFAMIDE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; UTERINE CERVICAL NEOPLASMS;

EID: 47249134222     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2008.01199.x     Document Type: Article

References (21)

1. NCI issues clinical announcement on cervical cancer: chemotherapy plus radiation improves survival. Available at : http://www.nih.gov/news/pr/feb99/ nci-22.htm. Accessed February 22, 1999.
2. Rose PG, Ali S, Watkins E et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin or cisplatin-based combination chemotherapy or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group study. J Clin Oncol 2007 25 : 2804 10.
3. Pearcey R, Miano Q, Kong W, Zhang-Salomons J, Mackillop WJ. Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population-based cohort study. J Clin Oncol 2007 25 : 2383 8.
4. Buda A, Dell'Anna T, Signorelli M, Mangioni C. Role of ifosfamide in cervical cancer: an overview. Oncology 2003 65 : 63 6.
5. Desoize B, Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment. Crit Rev Oncol Hematol 2002 42 : 317 25.
6. Kato T, Nishimura H, Yakushiji M et al. Phase II study of 254-S (cis-diammine glycolate platinum) for gynecological cancer in Japanese Gan To Kagaku Ryoho 1992 19 : 695 701.
7. Noda K, Takeuchi S, Kurihara S et al. Phase II study of cisplatin for cervical and endometrial carcinomas in Japanese Gan To Kagaku Ryoho 1987 14 : 1129 35.
8. Noda K, Kato T, Ikeda M et al. Phase II study of carboplatin in cervical cancer in Japanese Gan To Kagaku Ryoho 1988 15 : 3067 72.
9. Green JA, Kirwan JM, Tierney JF et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001 358 : 781 6.
10. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999 340 : 1144 53.
11. Swisher EM, Swensen RE, Greer B et al. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium. Gynecol Oncol 2006 101 : 429 35.
12. DiSilvestro PA, Walker JL, Morrison A, Rose PG, Homesley H, Warshal D. Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group. Gynecol Oncol 2006 103 : 1038 42.
13. Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Gynecol Oncol 2005 96 : 168 72.
14. Varveris H, Kachris S, Mazonakis M et al. Phase I/II trial of external irradiation plus medium-dose brachytherapy given concurrently to liposomal doxorubicin and cisplatin for advanced uterine cervix carcinoma. Strahlenther Onkol 2006 182 : 125 34.
15. Omura GA, Blessing JA, Vaccarello L et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin-ifosfamide in advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1997 15 : 165 71.
16. Kim YB, Cho JH, Keum KC et al. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors. Gynecol Oncol 2007 104 : 58 63.
17. Green JA, Kirwan JM, Tierney JF et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001 358 : 781 6.
18. Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995 32 : 1275 88.
19. Small W, Winter K, Levenback C et al. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm 1 of RTOG 0116. Int J Radiat Oncol Biol Phys. In press.
20. Tonkin KS, Kelland LR, Steel GG. Chemotherapy-radiation interactions in human cervix carcinoma xenografts. Br J cancer 1988 58 : 738 41.
21. Vrdoljak E, Omrcen T, Saratlija Z et al. Concomitant chemoradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix-final results of a prospective phase II-study. Gynecol Oncol 2006 103 : 494 9.